Gimap5 promoted RSV degradation through interaction with M6PR.

Pei DaiPinglang RuanYu MaoZhongxiang TangXiangjie QiuOusman BajinkaYu-Rong Tan

Published in: Journal of medical virology (2022)

Gimap5 promotes the degradation of RSV and its receptor through interacting with M6PR. Gimap5 agonists can effectively reduce RSV infection and RSV-induced complication in vivo and in vitro, which provides a new choice for the treatment of RSV. This article is protected by copyright. All rights reserved.

Keyphrases

respiratory syncytial virus
respiratory tract
high glucose
drug induced
endothelial cells
decision making
stress induced